• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home Investing

The Effects of Expanding Optometrists’ Scope of Practice

by
October 22, 2024
in Investing
0
The Effects of Expanding Optometrists’ Scope of Practice
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Jeffrey Miron

The standard argument for scope-of-practice (SOP) laws—and more generally, for occupational licensing—is that such regulation improves the quality of services by keeping out lower-skill providers. If so, then these government-created barriers to entry are potentially beneficial, even if they reduce supply and raise prices.

One problem with this perspective is that existing evidence does not find improvements in quality from SOP or licensing laws, and a new study confirms:

The United States is experiencing a shortage of physicians—exacerbated by the COVID-19 pandemic—and the shortage is expected to worsen primarily because of population growth and aging. Notably, the availability of ophthalmologists is trending downward despite growing demand for eye care. … Given the limited availability of ophthalmologists, some have suggested leveraging optometrists, who also have skills in eye care. …

And, lo and behold,

Beginning in the 1970s, optometrists gradually obtained the authority to prescribe medications. This scope-of-practice expansion has allowed optometrists to diagnose and treat patients with eye diseases or disorders without referrals to ophthalmologists. …

States have introduced and expanded optometrists’ prescription authority in multiple phases. Initially, optometrists were permitted to administer medications only for diagnostic purposes. Then, states allowed optometrists to prescribe medications for treatment purposes—known as therapeutic pharmaceutical agent (TPA) prescription authority. …

Our research estimates the effects of optometrists’ TPA prescription authority…. Specifically, it examines the effect of laws that allow optometrists to prescribe drugs for glaucoma treatment on public eye health. …

Our estimates provide evidence that granting TPA prescription authority to optometrists improved public eye health and increased optometrists’ earnings. Vision impairment declined by 12 percent on average over a 15‐​year period after the policy change.

Thus, rather than improving customer outcomes, SOP laws made them worse. So why do such laws exist? Presumably as protectionism for suppliers who want to avoid competition (but claim they are helping consumers). Bootleggers and Baptists lives!

This article appeared on Substack on October 22, 2024.

Previous Post

The Secret Economic Theory Behind the $100,000 Birkin Bag

Next Post

Americans Trust Trump on Economy, but “Experts” Don’t?

Next Post

Americans Trust Trump on Economy, but “Experts” Don’t?

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.